For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated.

A large study found pregnant women infected with SARS-CoV-2 had a lower incidence of Long COVID compared to non-pregnant ...

Moscow said there is "no evidence of a new or unidentified virus" as viral rumors spread on Russian social media.

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

The new XEC variant has been detected in 27 countries across Europe, Asia and North America and it has already been shown to ...

Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...

Trump administration has now targeted Covid-19-related research grants for termination, citing the pandemic as being over.

Sniffles? It must be flu.’ We often label minor illnesses as influenza, but the flu is far more dangerous, claiming thousands ...

Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

ME/CFS was found to occur in 4.5 percent of infected participants versus just 0.6 percent of uninfected participants. Almost ...

CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...